|
Sponsored by:
|
Citigroup (C) |
Yahoo (YHOO) |
Dow Chemical (DOW) |
Netflix (NFLX) |
Apple (AAPL) |
Focus Stocks
AstraZeneca Close to the 50 Day
Published on Wednesday, 01 September 2010 18:44 Written by Christian Paolinetti
New York, September 1st (TradersHuddle.com) - Shares of AstraZeneca PLC (NYSE:AZN) closed the trading day at $50.49 close to its 50 day moving average currently set at $49.70. AstraZeneca's price action is just above this important support level translating into a trading opportunity.
AstraZeneca PLC (NYSE:AZN), through its subsidiaries, researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.
Looking at peaks and troughs horizontal support and resistance levels, we can see current calculated support at $47.95 and calculated resistance at $53.53. These levels should also be evaluated by traders when planning their trades, as they provide an insight into the latest price action.
Traders wanting to establish a position on AstraZeneca will be looking at the price action for evidence of buying near the 50 day moving average, and opening a position as close as possible to this important level. Also traders will be looking at the latest price action, via the stocks current range previously defined for insights of other key levels that might affect their upside or downside.
Related Articles
- Sellers in Control - AstraZeneca
- AstraZeneca Fourth Quarter and Full-Year 2011 Results - Interviews
- AstraZeneca Earnings Preview
- AstraZeneca, United Way of Delaware Kick Off Statewide Youth Health Initiative
- Bristol-Myers Squibb and AstraZeneca Receive Complete Response Letter from U.S. Food and Drug Administration for Dapagliflozin
- Critical Alerts for Wal-Mart, BP, AstraZeneca, HCP, and Varian Medical Released by Seven Summits Research
- Up/Downgrades (ARB, BCS, BLK, SAM, NSC, PSUN, SAP, AZN, ED, CEG, EXC, GOOG, NOK, RAI, SNY, UPS, YHOO)
- Stock Futures Higher on European News. Stocks to Watch: AAPL, T, BAC, GIS, NKE, ORCL, RHT, S
- New Data Show Investigational Compound Dapagliflozin When Added to Glimepiride Maintained Reductions in Blood Sugar Levels in Adults with Type 2 Diabetes Over 48 Weeks of Treatment
- AstraZeneca to streamline US Sales Organization
Related Partner Headlines
- Notable Put Options Activity in AstraZeneca - Benzinga
- AstraZeneca To Cut 7,300 Jobs, Projects Drop In Profit - Benzinga
- Theravance Shares Slide on Lung Drug Deaths - TheStreet.com
- Deutsche Telekom, Lockheed: Hot Trends - TheStreet.com
- AstraZeneca PLC (AZN): Today's Featured Drugs Loser - TheStreet.com
- Targcept Trial Tragedy Takeaway: Don't Trust Clinical Data From India - TheStreet.com
- Targacept Depression Drug Fails Late-Stage Study - TheStreet.com
- AstraZeneca PLC (AZN): Today's Featured Drugs Winner - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
-
Oil States Breaking Out? -
Trading Idea - Buffalo Wild Wings Breaking Out? -
Google Approaching its 50 Day -
Paychex Close to 50 Day Moving Average -
Closing in to Support? -
Approaching Resistance - Netflix -
Carnival Expecting Resistance Soon? -
Trading Idea - Pioneer Natural Resources Broke Resistance, What to Expect? -
Playing the Setup in Willis Group -
Trading Idea - Franklin Resources Breaking Out? -
Trading Idea - Donaldson Broke Resistance, What to Expect? -
Quiksilver Broke Resistance
Latest Partner Headlines
-
Facebook's IPO Fortune: Tech Weekly Recap - TheStreet.com -
Private Equity Has a 'Social Responsibility': Carlyle Founder - TheStreet.com -
Foreclosure Settlement Will Settle Nothing - TheStreet.com -
Benzinga's Top ETF Decliners, February 3rd - Benzinga -
Benzinga's Top ETF Gainers, February 3rd - Benzinga -
'Mad Money Lightning Round': Kraft Foods Heading Higher - TheStreet.com -
Falling Earnings Hit Goldman CEO Blankfein's Pay - TheStreet.com -
Research In Motion's Dangerous Waiting Game - TheStreet.com -
Cramer's 'Mad Money' Recap: Next Week's Game Plan (Update 1) - TheStreet.com -
Benzinga's M&A Chatter for Friday February 3, 2012 - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,862.23 Trade time:4:03PM EST Value change:▲156.82 (1.23%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,344.90 Trade time:4:33PM EST Value change:▲19.36 (1.46%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,905.66 Trade time:5:16PM EST Value change:▲45.98 (1.61%)In The Wires
-
Vicks® NyQuil® and Vicks DayQuil® Reveal the NFL Player Least Likely to Take a Sick Day on Super Bowl XLVI -
Colorado’s Fresh Snow Brings Low Fares on Frontier Airlines -
SGOCO Group, Ltd. Relocates Corporate Headquarters to Beijing -
SGOCO Group, Ltd. Receives NASDAQ Deficiency Notification -
Security Bank of California Completes the Acquisition of Its Orange Office -
Record Earnings Announced by County Commerce Bank for 4th Quarter 2011 -
Cardinal Health Statement Regarding Temporary Restraining Order to Avoid Disruption in Controlled Medicine Shipments From Florida -
Bank of Santa Clarita Reports Record Pre-Tax Earnings -
Faruqi & Faruqi, LLP Files Securities Class Action Suit Against China Medical Technologies, Inc. and Certain of Its Executives -
Heritage Oaks Bancorp to Present at Fig Partners 3rd Annual West Coast CEO Forum










